Lead-Time Models Should Not Be Used to Estimate Overdiagnosis in Cancer Screening-Reference-Cited by-同舟云学术

Lead-Time Models Should Not Be Used to Estimate Overdiagnosis in Cancer Screening

Published:2014-03-04 Issue:9 Volume:29 Page:1283-1286
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Zahl Per-Henrik,Jørgensen Karsten Juhl,Gøtzsche Peter C.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11606-014-2812-2.pdf

Reference12 articles.

1. Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158:831–839.

2. Zahl P-H, Jørgensen KJ, Gøtzsche PC. Overestimated lead-time in cancer screening has led to substantial under-estimating of overdiagnosis. Br J Cancer. 2013;109:2014–2019.

3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6, CD001877. doi: 10.1002/14651858.CD001877.pub5 .

4. Zahl P-H, Strand BH, Mæhlen J. Breast cancer incidence in Norway and Sweden during introduction of nation-wide screening: prospective cohort study. BMJ. 2004;328:921–924.

5. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2023-03-14

2. Over-Diagnosis and Breast Cancer Screening;Screening and Risk Reduction Strategies for Breast Cancer;2023

3. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort;Annals of Internal Medicine;2022-04

4. The current status of risk-stratified breast screening;British Journal of Cancer;2021-10-26

5. Breast cancer over-diagnosis: an adverse consequence of mammography screening – highlights of the 2018 Kyoto Breast Cancer Consensus Conference;Future Oncology;2019-04